The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially ...
MedPage Today on MSN
FDA Gives Broad Approval to Gene Therapy for Rare Neurologic Disease
The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in ...
The therapy, branded as Itvisma, was approved for the treatment of spinal muscular atrophy patients of age two years and ...
Novartis secures FDA approval for Itvisma, a one-time gene therapy designed to boost motor function across a broad SMA ...
The FDA recently removed a black box warning on hormone replacement therapy, a treatment that has been an obstacle for ...
The FDA approved the first drug from an emerging class of medicines for patients with a chronic, autoimmune kidney disease.
Pfizer and Astellas Pharma have received FDA approval for PADCEV, an antibody-drug conjugate, in combination with Keytruda as ...
Boar’s Head Grated Pecorino Romano Cheese, Locatelli Pecorino Romano Grated Cheese and wedges of Boar's Head Pecorino Romano ...
Pecorino Romano cheese products are being recalled due to possible listeria contamination, the Food and Drug Administration ...
Agency abruptly withdraws plan to require standardized asbestos testing • Move contradicts congressional mandate in 2022 ...
The U.S. Food and Drug Administration on Tuesday extended its review of Ascendis Pharma's therapy for children with a rare genetic disorder that causes dwarfism, the company said.
The lab, led by Carleara Weiss, explores the relationship between Alzheimer’s disease and biomarkers of neurodegeneration, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback